Continuous Venovenous Hemodialysis

Solute removal depends on concentration differences across the hemofilter’s semipermeable membrane. Dialysate flows along the opposite side of the membrane, creating conditions in which substances such as urea move from the blood toward the dialysate down their concentration gradients. This mechanism provides gradual clearance rather than relying primarily on pressure-driven fluid movement.

The semipermeable membrane separates blood from dialysate while permitting the exchange process needed for solute clearance. Its arrangement within the hemofilter allows dialysate to flow alongside blood without the two fluids directly mixing. This separation supports controlled movement of waste products, including urea, through diffusion across the membrane.

Transmembrane pressure drives fluid removal across the hemofilter membrane. Unlike urea clearance, which occurs through movement down a concentration gradient, excess fluid is removed through pressure acting across the membrane. This distinction helps explain how CVVHD can address both solute accumulation and fluid overload within the same continuous treatment approach.

CVVHD removes waste and fluid gradually over an ongoing period, rather than producing the more rapid changes associated with conventional intermittent dialysis. This slower, sustained approach is useful when critically ill patients cannot tolerate abrupt treatment effects. Its continuous operation also allows close adjustment as hemodynamic conditions change during clinical care.

Clinical teams may use CVVHD to support patients with acute kidney injury, severe electrolyte disturbances, acid-base disturbances, or fluid overload. Its value lies in addressing these problems through sustained clearance and fluid removal while accommodating critical illness. The approach is especially relevant when conventional intermittent dialysis is not well tolerated.

Because the therapy operates continuously, clinicians can make close adjustments in response to changing hemodynamic conditions. The treatment simultaneously provides dialysate-based diffusive solute clearance and pressure-mediated fluid removal through the hemofilter. This ongoing control makes the method suitable for critically ill patients whose clinical status may require gradual, sustained support rather than a fixed intermittent intervention.